Bio-Rad Laboratories, Inc. BIO.B

365.08 0.00 0.00% as of 24 Sep
Market cap
$10.3B
P/E
43.8×
Growth Flags show if company had growth for consecutive years
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
190.78 61.72 18.88 6.27 4.49 5.07 0.00 0.00 0.00 11.12
P/S ratio
2.61 3.27 3.00 4.77 6.71 7.38 4.30 3.51 3.58 3.28
P/FCF ratio
72.05 0.00 42.89 29.95 35.61 40.00 143.80 42.49 31.49 22.49
P/Operating CF
56.91 101.90 65.35 69.02 58.06 126.21 151.40 115.62 73.97 51.37
P/B ratio
2.09 2.41 1.71 1.92 1.73 1.58 1.25 1.07 1.40 1.14
Price to Tangible BV
2.78 3.14 1.87 2.06 1.82 1.65 1.36 1.17 1.57 1.26
EV/Sales
2.41 3.12 2.82 4.48 6.33 7.08 4.09 3.35 3.40 3.15
EV/EBITDA
30.04 29.92 0.00 45.06 38.23 41.37 23.74 26.50 32.43 172.31
EV/Operating CF
23.06 64.72 22.60 22.60 27.54 30.92 58.92 23.88 19.16 15.28
EV/FCF
66.58 (610.54) 40.33 28.10 33.57 38.39 136.67 40.62 29.90 21.59
Quick Ratio
2.58 2.44 2.76 1.67 2.24 1.91 4.03 4.02 4.53 3.87
Current Ratio
3.91 3.93 4.49 2.41 3.39 2.92 5.55 5.83 6.48 5.62
Net Debt/EBITDA
(7.36) (2.73) 3.98 (2.96) (2.33) (1.73) (1.24) (1.22) (1.72) (7.15)
Debt/Assets
11.28% 10.18% 7.83% 5.49% 0.11% 0.06% 8.87% 9.75% 12.83% 11.37%
Debt/Equity
0.17 0.15 0.11 0.08 0.00 0.00 0.12 0.14 0.18 0.16
Asset Turnover
0.55 0.53 0.46 0.34 0.24 0.19 0.18 0.21 0.24 0.26
Operating CF/Net income
8.31 0.85 0.78 0.26 0.15 0.16 (0.05) (0.59) (0.25) 0.70
Capex/Depreciation
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
1.03% 4.44% 10.52% 35.98% 48.79% 36.11% (31.14%) (6.94%) (24.09%) 10.84%
ROA
0.69% 3.01% 7.40% 25.83% 36.36% 27.65% (23.18%) (4.94%) (17.03%) 7.62%
ROIC
1.61% 2.86% (1.79%) 2.83% 2.96% 2.44% 3.34% 2.54% 2.75% 0.41%
Return on Tangible Assets
1.40% 6.21% 17.57% 99.14% 190.74% 233.60% (117.48%) (20.86%) (59.67%) 25.94%
Average Days of Receivables
65.71 78.55 62.57 62.00 60.14 52.90 64.43 66.82 64.35 65.08
Research and Development Expense of Revenue
9.95% 11.58% 8.70% 8.77% 8.55% 8.92% 9.17% 9.26% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
39.39% 37.35% 36.46% 35.67% 31.38% 30.01% 29.54% 31.51% 31.72% 32.68%
Intangible Assets out of Total Assets
0.17 0.16 0.06 0.05 0.04 0.03 0.05 0.06 0.08 0.07
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Graham Net Nets
0.11 0.09 0.06 (0.01) (0.06) (0.10) (0.06) (0.05) 0.03 (0.03)
Graham Number
43.50 92.64 192.17 505.67 977.42 1,213.40 0.00 0.00 0.00 414.65
Earnings Yield
0.52% 1.62% 5.30% 15.94% 22.28% 19.73% (29.98%) (6.69%) (19.96%) 9.00%
Free Cash Flow Yield
1.39% (0.16%) 2.33% 3.34% 2.81% 2.50% 0.70% 2.35% 3.18% 4.45%
Revenue per Share
70.25 72.84 76.73 77.46 85.52 97.97 94.08 91.45 90.97 94.75
Operating CF per Share
7.34 3.51 9.57 15.34 19.65 22.44 6.53 12.84 16.13 19.52
Capex per Share
(4.80) (3.88) (4.21) (3.00) (3.53) (4.48) (3.83) (5.36) (5.87) (5.78)
Free Cash Flow per Share
2.54 (0.37) 5.36 12.34 16.12 17.96 2.70 7.48 10.27 13.74
Cash per Share
28.67 25.65 28.50 37.54 33.48 29.35 60.31 55.21 59.00 56.51
Shareholders Equity per Share
87.61 98.81 134.75 192.84 331.90 458.76 322.82 299.26 232.84 273.40
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
87.61 98.81 134.75 192.84 331.90 458.76 322.82 299.26 232.84 273.40
Free Cash Flow
74.89 (10.90) 159.98 368.31 479.89 535.77 80.30 218.40 289.70 374.70
Working Capital
1,373.20 1,473.95 1,572.68 1,274.66 1,508.30 1,309.54 2,589.27 2,525.50 2,562.50 2,389.20
Capital Expenditures
(141.17) (115.04) (125.51) (89.58) (105.08) (133.69) (114.10) (156.50) (165.50) (157.50)
Net Current Asset Value
573.18 633.89 432.74 (73.65) (952.84) (2,123.68) (728.44) (509.60) 235.50 (216.70)
EV/EBIT
89.42 56.52 0.00 45.06 38.23 41.37 23.74 26.50 32.43 172.31
Capex to Sales
0.07 0.05 0.05 0.04 0.04 0.05 0.04 0.06 0.06 0.06
Net Profit Margin
1.26% 5.66% 15.97% 76.08% 149.83% 145.57% (129.45%) (23.86%) (71.86%) 29.42%
Price to Operating Income
96.77 59.25 0.00 48.03 40.57 43.10 24.97 27.73 34.15 179.46
Other line items
Depreciation/Fixed assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash ROIC
(7.07%) (9.44%) (4.20%) (0.57%) 0.86% 1.08% (2.41%) (1.33%) (0.77%) (0.08%)
Accounts Receivable Turnover
5.42 5.16 5.34 5.89 6.27 6.93 6.10 5.43 5.45 5.66
Accounts Payable Turnover
7.28 7.25 8.28 9.19 8.99 9.13 8.92 8.90 8.90 9.89
Inventory Turnover
1.83 1.74 1.81 1.85 1.88 2.15 1.91 1.66 1.54 1.66
Average Days of Payables
52.26 50.74 41.92 37.04 45.95 40.34 39.91 42.42 37.59 37.87
Days of Inventory on Hand
206.09 223.25 199.85 191.73 205.03 162.61 212.61 228.95 233.58 217.45
Average Receivables
381.92 418.60 428.65 392.56 406.05 421.48 459.09 491.82 470.75 456.55
Average Payables
127.75 134.15 128.82 114.73 123.23 140.70 138.49 139.82 133.45 125.65
Average Inventory
507.59 559.88 589.31 568.91 588.13 597.25 645.78 749.91 770.25 750.35
Average Assets
3,780.11 4,061.76 4,942.04 6,809.96 10,490.74 15,386.01 15,650.53 12,900.39 10,831.60 9,970.30
Average Common Equity
2,534.83 2,754.71 3,475.29 4,887.69 7,817.50 11,782.59 11,650.25 9,178.23 7,655.25 7,011.45

Fold the line items

Columns are period end dates